This is a drug monograph from the BSAVA Small Animal Formulary Part A: Canine and Feline. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
Blais M-C, Bianco D, Goggs R et al. (2019) Consensus on the rational use of antithrombotics in veterinary critical care (CURATIVE): domain 3-defining antithrombotic protocols.Journal of Veterinary Emergency and Critical Care29, 60–74
Morassi A, Bianco D, Park E, Nakamura RK and White GA (2016) Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.Journal of Veterinary Emergency and Critical Care26, 488–494
Johnson & Johnson Pharmaceutical Research & Development LLC. Xarelto (rivaroxaban) [FOIA - Pharmacology Review]. Raritan, NJ, USA; 2009. Available at: www.vin.com/members/viewer/viewer.ashx?DocumentId=9416008&FileTypeId=6
Goggs R, Blais M-C, Brainard BM et al.(2019) Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE) guidelines: Small Animals.Journal of Veterinary Emergency and Critical Care29, 12–36
Dixon-Jimenez AC, Brainard BM, Brooks MB et al. (2016) Pharmacokinetic and pharmacodynamic evaluation of oral rivaroxaban in healthy adult cats. Journal of Veterinary Emergency and Critical Care26, 619–629
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
